JP2021532095A5 - - Google Patents
Info
- Publication number
- JP2021532095A5 JP2021532095A5 JP2021502870A JP2021502870A JP2021532095A5 JP 2021532095 A5 JP2021532095 A5 JP 2021532095A5 JP 2021502870 A JP2021502870 A JP 2021502870A JP 2021502870 A JP2021502870 A JP 2021502870A JP 2021532095 A5 JP2021532095 A5 JP 2021532095A5
- Authority
- JP
- Japan
- Prior art keywords
- stem cells
- human
- pharmaceutical composition
- mitochondrial
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862701783P | 2018-07-22 | 2018-07-22 | |
| US62/701,783 | 2018-07-22 | ||
| US201862753939P | 2018-11-01 | 2018-11-01 | |
| US62/753,939 | 2018-11-01 | ||
| PCT/IL2019/050824 WO2020021537A1 (en) | 2018-07-22 | 2019-07-22 | Mitochondrial augmentation therapy of liver diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021532095A JP2021532095A (ja) | 2021-11-25 |
| JP2021532095A5 true JP2021532095A5 (enExample) | 2022-07-27 |
Family
ID=69181382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021502870A Pending JP2021532095A (ja) | 2018-07-22 | 2019-07-22 | 肝臓疾患のミトコンドリア増強療法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20210252075A1 (enExample) |
| EP (1) | EP3823643A4 (enExample) |
| JP (1) | JP2021532095A (enExample) |
| WO (1) | WO2020021537A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL282198B2 (en) | 2011-09-11 | 2025-11-01 | Minovia Therapeutics Ltd | Compositions of functional mitochondria and uses thereof |
| US11951135B2 (en) | 2018-07-22 | 2024-04-09 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of muscle diseases |
| EP3823646A4 (en) | 2018-07-22 | 2022-06-08 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of brain diseases |
| WO2020021535A1 (en) | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of ocular diseases |
| AU2019311859B2 (en) | 2018-07-22 | 2025-12-18 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy for primary mitochondrial diseases |
| JP7586811B2 (ja) * | 2018-07-22 | 2024-11-19 | ミノヴィア セラピューティクス リミテッド | 腎臓疾患のミトコンドリア増強療法 |
| EP3823644A4 (en) | 2018-07-22 | 2022-06-08 | Minovia Therapeutics Ltd. | MITOCHONDRIAL AUGMENTATION THERAPY OF PANCREATIC DISEASES |
| BR112022019609A2 (pt) * | 2020-03-31 | 2022-11-29 | Minovia Therapeutics Ltd | Células geneticamente modificadas enriquecidas com mitocôndrias e usos das mesmas |
| TWI780431B (zh) * | 2020-05-08 | 2022-10-11 | 台灣粒線體應用技術股份有限公司 | 新穎性醫藥組合物及其於修復肝臟損傷、治療肝臟損傷相關疾病與提升肝臟功能之用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9603872B2 (en) * | 2007-05-02 | 2017-03-28 | The McLeon Hospital Corporation | Methods and compositions for mitochondrial replacement therapy |
| IL282198B2 (en) * | 2011-09-11 | 2025-11-01 | Minovia Therapeutics Ltd | Compositions of functional mitochondria and uses thereof |
| WO2016008937A1 (en) * | 2014-07-16 | 2016-01-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the intercellular transfer of isolated mitochondria in recipient cells |
| IL299482B2 (en) * | 2015-02-26 | 2025-02-01 | Minovia Therapeutics Ltd | Mammalian cells are enriched with active mitochondria |
| MA41757A (fr) * | 2015-02-27 | 2018-01-03 | Univ Connecticut | Transplantation ciblée de mitochondries dans des hépatocytes |
| JP7187036B2 (ja) * | 2016-11-14 | 2022-12-12 | パイアン バイオテクノロジ－ インコーポレイテッド | 外因性ミトコンドリアを細胞内に送達する方法 |
| JP2020502078A (ja) * | 2016-11-30 | 2020-01-23 | パイアン・バイオテクノロジー・インコーポレイテッドＰａｅａｎ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ Ｉｎｃ． | ミトコンドリアを含む医薬組成物 |
-
2019
- 2019-07-22 EP EP19840774.4A patent/EP3823643A4/en active Pending
- 2019-07-22 US US17/255,840 patent/US20210252075A1/en not_active Abandoned
- 2019-07-22 JP JP2021502870A patent/JP2021532095A/ja active Pending
- 2019-07-22 WO PCT/IL2019/050824 patent/WO2020021537A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021532095A5 (enExample) | ||
| Zhidu et al. | Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities | |
| JP2021532091A5 (enExample) | ||
| Han et al. | The secretion profile of mesenchymal stem cells and potential applications in treating human diseases | |
| Li et al. | Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice | |
| JP2021532094A5 (enExample) | ||
| Galderisi et al. | Clinical trials based on mesenchymal stromal cells are exponentially increasing: where are we in recent years? | |
| Xie et al. | What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment? | |
| Zhao et al. | Emerging role of mesenchymal stem cell-derived exosomes in regenerative medicine | |
| Lee et al. | Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease | |
| Sordi | Mesenchymal stem cell homing capacity | |
| Yagi et al. | Mesenchymal stem cells: mechanisms of immunomodulation and homing | |
| US20120201791A1 (en) | Methods of treating diseases or conditions using mesenchymal stem cells | |
| JP2021531288A5 (enExample) | ||
| Zhuang et al. | Mesenchymal stem cell–based therapy as a new approach for the treatment of systemic sclerosis | |
| JP2022519409A5 (enExample) | ||
| JP2021532093A5 (enExample) | ||
| Zhou et al. | Therapeutic effects of adipose-derived stem cells-based microtissues on erectile dysfunction in streptozotocin-induced diabetic rats | |
| RU2014108878A (ru) | Лечение заболевания периферических сосудов при помощи клеток, полученных из ткани пуповины | |
| Shukai et al. | Allogeneic compact bone-derived mesenchymal stem cell transplantation increases survival of mice exposed to lethal total body irradiation: a potential immunological mechanism | |
| JP2016138092A (ja) | 肝疾患を治療するための間葉系幹細胞 | |
| US20170204151A1 (en) | Mesenchymal Stem Cells Expressing Biomarkers that Predict the Effectiveness of Mesenchymal Stem Cells for Treating Diseases and Disorders | |
| Eom et al. | Mesenchymal stem cell therapy for liver disease: current status and future perspectives | |
| JP2021531281A5 (enExample) | ||
| Lin et al. | Cardiac adipose tissue contributes to cardiac repair: A review |